The carbonyl nucleobase adduct MAde is a potent antigen for adaptive polyclonal MR1-restricted T cells.

The major histocompatibility complex (MHC) class I-related molecule MHC-class-I-related protein 1 (MR1) presents metabolites to distinct MR1-restricted T cell subsets, including mucosal-associated invariant T (MAIT) and MR1T cells. However, self-reactive MR1T cells and the nature of recognized antigens remain underexplored. Here, we report a cell endogenous carbonyl adduct of adenine (8-(9H-purin-6-yl)-2-oxa-8-azabicyclo[3.

Combining real-space and local range separation-The MH24 locally range-separated local hybrid functional.

In this work, the development of a new general-purpose exchange-correlation hybrid functional based on the recent locally range-separated local hybrid approach is presented. In particular, the new functional, denoted as MH24, combines a non-empirical treatment of the admixture of locally range-separated long-range exact exchange with a new real-space separation approach for the real-space exact-exchange admixture governed by the local mixing function (LMF) and a new empirical LYP-based approach for the correlation functional to enable a flexible description of same- and opposite-spin correlation effects. The nine empirical parameters of the MH24 model have been optimized using a state-of-the-art super-self-consistent-field approach, which exploits the sensitivity of specific properties, such as core ionization potentials, electron affinities, and atomization energies, to the exact-exchange admixture in specific regions in real space and the separation of the LMF into a core, valence, and asymptotic part.

Recombinase polymerase amplification in combination with electrochemical readout for sensitive and specific detection of PIK3CA point mutations.

As part of the ongoing evolution towards personalized anticancer therapy, mutation screening is becoming increasingly important and, therefore, also alternative detection strategies that allow for fast genetic diagnostics at the point of care. In the case of breast cancer, detecting cancer-associated point mutations in the PIK3CA gene is of particular importance for treatment decisions. We developed a recombinase polymerase amplification assay combined with an enzyme-linked electrochemical assay on multi-channel screen-printed gold sensors for specific and highly sensitive detection of three PIK3CA point mutations (H1047R, E545K, and E542K).

Nitro-fatty acids: promising agents for the development of new cancer therapeutics.

Nitro-fatty acids (NO-FAs) are endogenous pleiotropic lipid mediators regarded as promising drug candidates for treating inflammatory and fibrotic diseases. Over the past two decades, the anti-inflammatory and cytoprotective actions of NO-FAs and several molecular targets have been identified. More recently, preclinical studies have demonstrated their potential as prospective cancer therapeutics with favorable safety and tumor-selective profiles.